4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-022359
EVP, CHIEF FINANCIAL OFFICER sold 22,000 shares at $25.18 ($554,024)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-08-18 | Sale 10b5-1 | −22,000 | $25.18 | $554,024 | 40,130 | D |
| Open-market sales · 22,000 sh · avg $25.18 · $554,024 | |||||||
Loading xslF345X05/form4-08192025_060803.xml…